Background Live vaccines are generally contraindicated on immunosuppressive therapy
due to safety concerns. However, data are limited to corroborate this practice. Objectives To …

Vaccinations are often the most effective tool against some disease known to mankind. This
study offers a literature review on the role of vaccines regarding the risk of developing …

Background: Since vaccination against coronavirus disease 2019 (COVID-19) became
available, risks related to vaccinating patients with multiple sclerosis (MS) need to be …

The availability of vaccines against the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), provides hope towards mitigation of the coronavirus disease 2019 (COVID …

An international panel of experts prepared an evidenced-based guideline for vaccination of
immunocompromised adults and children. These guidelines are intended for use by primary …

Zusammenfassung Zum Erreichen eines optimalen Schutzes vor impfpräventablen
Erkrankungen werden im Folgenden Anwendungshinweise für die von der STIKO …

Relapses (episodic exacerbations of neurological signs or symptoms) are a defining feature
of relapsing-remitting multiple sclerosis (MS), the most prevalent MS phenotype. While their …

A wide variety of inflammatory diseases temporally associated with the administration of
various vaccines, has been reported in the literature. A PubMed search from 1979 to 2013 …

Background: Patients with multiple sclerosis (MS) are at increased risk of infection.
Vaccination can mitigate these risks but only if safe and effective in MS patients, including …

Mounting evidence indicates that infection with Epstein–Barr virus (EBV) has a major role in
the pathogenesis of multiple sclerosis (MS). Defective elimination of EBV‐infected B cells by …